Having trouble viewing this email? View in your browser.
 
Weekly News
5 October 2021

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.

 
The ESCMID Awards nomination will close in one week!

For one more week you are still able to nominate your outstanding colleagues for the ESCMID Awards, including the Excellence, Young Investigator and Outstanding Trainee awards.

The call for 2022 ESCMID Awards will close on 12 October 2021, 17:00 CEST.

 
 
Applications open for ESCMID funded observerships

ESCMID opened today the first call in 2021 for funded Observerships. All ESCMID Young Scientists Members are invited to apply now. At the link below you will find the full eligibility criteria for one of the 50 prestigious Observerships. In case of questions, please contact: observership@escmid.org

Open call to join the ESCMID Guidelines Subcommittee

ESCMID is selecting a new member of the Guidelines Subcommittee. ESCMID members interested in joining the subcommittee can find the full call document here. The deadline to apply is 1 November 2021.

ESCMID Online Education Courses: sign up today!

Be sure to secure your place in the exciting ESCMID online education courses coming up in the coming 2 months. Don’t miss highlights such as ‘Infections in the elderly - from bench to (beyond) bed’, taking place from 14-15 October 2021.

Ecraid kick-off and launch

ESCMID is proud to be a part of Ecraid, the European Clinical Research Alliance for Infectious Diseases.  Ecraid officially launched on 14 September 2021, in an online event  attended by over 160 people. Find our more on the ECRAID website.

Open call to join the ESCMID Scientific Affairs Subcommittee

There is under 2 weeks to apply to join the Scientific Affairs Subcommittee within the theme of Epidemiology, Public Health and Vaccinology. Apply by 20 October 2021 and take an active role in the scientific activities of ESCMID. members interested in applying can find the full call document here.

HCMV infection during pregnancy: antibody response, risk and newborn outcome

This study evaluated the rate and risk factors for non-primary infection during pregnancy and estimated the rate of congenital cytomegalovirus infection. It found that although HCMV non-primary infection is frequent during pregnancy, rates of congenital infection as a result is likely less than 4%.